Expression of bone morphogenetic protein in the course of osteoinduction by recombinant human bone morphogenetic protein-2

被引:21
|
作者
Okubo, Y
Bessho, K
Fujimura, K
Kusumoto, K
Ogawa, Y
Iizuka, T
机构
[1] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, Kyoto 6068507, Japan
[2] Kansai Med Univ, Dept Plast & Reconstruct Surg, Osaka, Japan
关键词
recombinant human bone morphogenetic protein-2 (rhBMP-2); anti-BMP-2 monoclonal antibody; immunohistochemical study; osteoinduction;
D O I
10.1034/j.1600-0501.2002.130110.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
To clarify the mechanism of osteoinduction by recombinant human bone morphogenetic protein-2 (rhBMP-2), we examined the time-course localization of bone morphogenetic proteins (BMPs) immunostained by an anti-BMP-2 monoclonal antibody after implantation of pellets consisting of rhBMP-2 and collagen in rat calf muscle pouch. On day 3 after implantation, BMP was detected in the entire lump, and the intensity of staining for BMP around the implant on day 7 was weaker than that on day 3. The staining for BMP decreased with time and the region of staining for BMP remained more centralized in the implant. On day 10 after implantation, BMP was observed in part of the newly induced cartilage, especially around chondrocytes. On day 14 after implantation, BMP was localized in the newly induced woven bone. on day 21, BMP staining was found in osteoblasts at the surface of the newly induced bone. Especially, the staining for BMP decreased from day 10 to day 21. These results indicate that the woven bone was replaced with mature lamellar bone from day 14 to day 21. The present findings suggest that rhBMP-2 plays an important role in osteoinduction, especially at the early stage.
引用
收藏
页码:80 / 85
页数:6
相关论文
共 50 条
  • [1] Effect of elcatonin on osteoinduction by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) : 317 - 321
  • [2] Recombinant human bone morphogenetic protein-2
    Shaffrey, Christopher I.
    Smith, Justin S.
    JOURNAL OF NEUROSURGERY-SPINE, 2013, 18 (02) : 109 - 110
  • [3] Effect of FK506 on osteoinduction by recombinant human bone morphogenetic protein-2
    Kaihara, S
    Bessho, K
    Okubo, Y
    Sonobe, J
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    LIFE SCIENCES, 2002, 72 (03) : 247 - 256
  • [4] Osteoinduction by recombinant human bone morphogenetic protein-2 in muscles of non-human primates
    Kusumoto, K
    Bessho, K
    Fujimura, K
    Akioka, J
    Okubo, Y
    Wang, Y
    Iizuka, T
    Ogawa, Y
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2002, 30 (03) : 251 - 259
  • [5] Recombinant human bone morphogenetic protein-2 Response
    Burkus, J. Kenneth
    JOURNAL OF NEUROSURGERY-SPINE, 2013, 18 (02) : 110 - 111
  • [6] Osteoinduction by repeat plasmid injection of human bone morphogenetic protein-2
    Osawa, Kenji
    Okubo, Yasunori
    Nakao, Kazumasa
    Koyama, Noriaki
    Bessho, Kazuhisa
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 937 - 944
  • [7] The effect of nicotine on osteoinduction by recombinant human bone morphogenetic protein 2
    Tamura, K.
    Togo, Y.
    Kaihara, S.
    Hussain, A.
    Takahashi, K.
    Bessho, K.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2014, 43 (08) : 1022 - 1029
  • [8] Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites
    Okubo, Y
    Bessho, K
    Fujimura, K
    Konishi, Y
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2000, 29 (01) : 62 - 66
  • [9] Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration
    Hollinger, JO
    Schmitt, JM
    Buck, DC
    Shannon, R
    Joh, SP
    Zegzula, HD
    Wozney, J
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1998, 43 (04): : 356 - 364
  • [10] Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures
    Ghodadra, Neil
    Singh, Kern
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03): : 345 - 354